Loading clinical trials...
Loading clinical trials...
Vargatef in 2nd-line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung
Conditions
Interventions
treatment
Locations
1
Germany
Multiple Locations, Germany
Start Date
March 23, 2015
Primary Completion Date
July 23, 2025
Completion Date
July 23, 2025
Last Updated
July 28, 2025
NCT04165798
NCT06667908
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions